Industry

Trial will continue to assess additional primary endpoint of event-free survival WILMINGTON, Del.–(BUSINESS WIRE)–Positive high-level results from a planned interim analysis of the AEGEAN Phase III trial showed treatment with AstraZeneca’s IMFINZI® (durvalumab) in combination with neoadjuvant chemotherapy before surgery demonstrated a statistically significant and meaningful improvement in pathologic complete response (pCR) compared to neoadjuvant … [Read more…]

Alicia Boler Davis brings more than 25 years of experience leading world-class technology operations SAN FRANCISCO–(BUSINESS WIRE)–Alto Pharmacy today announced Alicia Boler Davis will become CEO on September 1, 2022. Alicia was recruited by co-founders and current co-CEOs Jamie Karraker and Matt Gamache-Asselin to scale the business that is transforming a $500 billion industry by … [Read more…]

SALT LAKE CITY–(BUSINESS WIRE)–Spectrum Solutions, LLC today announced it has been awarded two Utah Best of State Science & Technology Awards for Medical Innovation and Laboratory Equipment and Supplies. “We are extremely thankful for these two awards and being recognized with a win, for the second year in a row, under Medical Innovation,” said Bill … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Healthcare Distribution Market Research Report by Type, End User, State – United States Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The United States Healthcare Distribution Market size was estimated at USD 223.74 billion in 2021, USD 233.19 billion in 2022, and is projected to grow … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Rare Neurological Disease Treatment Market – Growth, Trends, COVID-19 Impact, and Forecasts (2022 – 2027)” report has been added to ResearchAndMarkets.com’s offering. The rare neurological disease treatment market is expected to register a CAGR of 8.6% during the forecast period. Companies Mentioned US WorldMeds LLC (Solstice Neurosciences LLC) CSL Ltd Merz Pharma GmbH … [Read more…]

LG Chem will now proceed with Investigational New Drug (IND) enabling studies for Affimer PD-L1 antagonist programme LONDON & WETHERBY, England–(BUSINESS WIRE)–Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary Affimer® and pre|CISION™ platforms, is pleased to announce that LG Chem Life Sciences … [Read more…]

PARIS–(BUSINESS WIRE)–Ermium Therapeutics, a Paris-based biotech company developing innovative health products for auto-immune diseases, announced today the extension of its initial funding of €6.3 M to €12.3 M with Kurma Partners and Fountain Healthcare Partners. The company is discovering and developing small molecules, orally available, that are aimed at addressing a range of chronic auto-immune … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Biopharmaceuticals Contract Manufacturing Market Research Report by Product, Source, Contract Type, Service, Scale of Operation, Therapeutic Applications, Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Biopharmaceuticals Contract Manufacturing Market size was estimated at USD 27.99 billion in 2021 and expected to … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Neonatal Ventilators Market – Growth, Trends, COVID-19 Impact, and Forecasts (2022 – 2027)” report has been added to ResearchAndMarkets.com’s offering. The global neonatal ventilators market studied was anticipated to grow with a CAGR of nearly 6.8% during the forecast period. Companies Mentioned Air Liquide Medical Systems India Breas Medical Drgerwerk AG & Co. … [Read more…]

PD-1 inhibitor tislelizumab plus chemotherapy demonstrated a statistically significant and clinically meaningful survival benefit, extending survival by more than six months compared to chemotherapy alone Incidence of most common treatment-related adverse events similar for both arms of the study, with no new safety signal identified for tislelizumab CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING–(BUSINESS WIRE)–$BGNE … [Read more…]